Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vanda Pharmaceuticals (VNDA) Change in Inventory (2016 - 2025)

Historic Change in Inventory for Vanda Pharmaceuticals (VNDA) over the last 13 years, with Q3 2025 value amounting to -$32000.0.

  • Vanda Pharmaceuticals' Change in Inventory fell 11495.33% to -$32000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.3 million, marking a year-over-year increase of 55702.01%. This contributed to the annual value of $29000.0 for FY2024, which is 9623.87% down from last year.
  • Vanda Pharmaceuticals' Change in Inventory amounted to -$32000.0 in Q3 2025, which was down 11495.33% from $368000.0 recorded in Q2 2025.
  • Vanda Pharmaceuticals' Change in Inventory's 5-year high stood at $1.8 million during Q1 2025, with a 5-year trough of -$263000.0 in Q2 2024.
  • Moreover, its 5-year median value for Change in Inventory was $368000.0 (2025), whereas its average is $510421.1.
  • Its Change in Inventory has fluctuated over the past 5 years, first tumbled by 13374.69% in 2023, then skyrocketed by 647931.03% in 2025.
  • Quarter analysis of 5 years shows Vanda Pharmaceuticals' Change in Inventory stood at $77000.0 in 2021, then surged by 1367.53% to $1.1 million in 2022, then tumbled by 62.21% to $427000.0 in 2023, then crashed by 74.94% to $107000.0 in 2024, then crashed by 129.91% to -$32000.0 in 2025.
  • Its Change in Inventory stands at -$32000.0 for Q3 2025, versus $368000.0 for Q2 2025 and $1.8 million for Q1 2025.